国际泌尿系统杂志
國際泌尿繫統雜誌
국제비뇨계통잡지
INTERNATIONAL JOURNAL OF UROLOGY AND NEPHROLOGY
2014年
5期
704-708
,共5页
前列腺炎%胶囊%肾上腺素能α拮抗剂
前列腺炎%膠囊%腎上腺素能α拮抗劑
전렬선염%효낭%신상선소능α길항제
Prostatitis Capsules%Adrenergic alpha-Antagonists
目的 前瞻性研究前列舒通胶囊联合α-1A受体阻滞剂治疗湿热瘀阻型Ⅲ型前列腺炎的临床疗效.方法 将121例湿热瘀阻Ⅲ型前列腺炎患者随机分为观察组和对照组,分别给予前列舒通胶囊(3粒,每天3次)+盐酸坦洛新胶囊(0.2mg,每晚1次)和盐酸坦洛新胶囊(0.2mg,每晚1次)治疗,8周后按照美国国立卫生研究所(NIH)制定的前列腺症状评分标准(CPSI)量化两组患者的症状积分,并观察治疗前后前列腺液中卵磷脂小体、WBC、PH值的变化,比较两组患者的临床疗效及其副作用.结果 经过8周的治疗,观察组和对照组的NIH-CPSI评分、QOL评分及EPS常规中白细胞数目均有显著下降(P＜0.01),但观察组下降的程度均较对照组明显(P＜0.01).结论 前列舒通胶囊联合α-1A受体阻滞剂治疗湿热瘀阻型Ⅲ型前列腺炎比单用α-1A受体阻滞剂疗效明显,值得临床推广.
目的 前瞻性研究前列舒通膠囊聯閤α-1A受體阻滯劑治療濕熱瘀阻型Ⅲ型前列腺炎的臨床療效.方法 將121例濕熱瘀阻Ⅲ型前列腺炎患者隨機分為觀察組和對照組,分彆給予前列舒通膠囊(3粒,每天3次)+鹽痠坦洛新膠囊(0.2mg,每晚1次)和鹽痠坦洛新膠囊(0.2mg,每晚1次)治療,8週後按照美國國立衛生研究所(NIH)製定的前列腺癥狀評分標準(CPSI)量化兩組患者的癥狀積分,併觀察治療前後前列腺液中卵燐脂小體、WBC、PH值的變化,比較兩組患者的臨床療效及其副作用.結果 經過8週的治療,觀察組和對照組的NIH-CPSI評分、QOL評分及EPS常規中白細胞數目均有顯著下降(P＜0.01),但觀察組下降的程度均較對照組明顯(P＜0.01).結論 前列舒通膠囊聯閤α-1A受體阻滯劑治療濕熱瘀阻型Ⅲ型前列腺炎比單用α-1A受體阻滯劑療效明顯,值得臨床推廣.
목적 전첨성연구전렬서통효낭연합α-1A수체조체제치료습열어조형Ⅲ형전렬선염적림상료효.방법 장121례습열어조Ⅲ형전렬선염환자수궤분위관찰조화대조조,분별급여전렬서통효낭(3립,매천3차)+염산탄락신효낭(0.2mg,매만1차)화염산탄락신효낭(0.2mg,매만1차)치료,8주후안조미국국립위생연구소(NIH)제정적전렬선증상평분표준(CPSI)양화량조환자적증상적분,병관찰치료전후전렬선액중란린지소체、WBC、PH치적변화,비교량조환자적림상료효급기부작용.결과 경과8주적치료,관찰조화대조조적NIH-CPSI평분、QOL평분급EPS상규중백세포수목균유현저하강(P＜0.01),단관찰조하강적정도균교대조조명현(P＜0.01).결론 전렬서통효낭연합α-1A수체조체제치료습열어조형Ⅲ형전렬선염비단용α-1A수체조체제료효명현,치득림상추엄.
Objectives To prospective study the clinical effect of the treatment of type Ⅲll prostatitis with QianlieShutong Capsule Combined with α1 A receptor blocker.Methods 120 patients with damp heat and blood stasis type Ⅲ prostatitis were randomly divided into observation group and control group,were treated with Qianlie Shutong Capsule (3capsules,3 times daily) plus tamsulosin hydrochloride capsules (0.2mg,1 night) and tamsulosin hydrochloride capsules (0.2 mg,every night 1) after 8 weeks treatment,according to American National Institutes of Health (NIH) formulation of the prostate symptom score (CPSI),international index of erectile function (IIEF-5) symptom quantization of two groups of patients,and observe the changes of lecithin in prostatic fluid,WBC,pH value of the body before and after the treatment,clinical efficacy compared two groups of patients and their side effects.Results After 8 weeks of treatment,the observation group and the control group,NIH-CPSI score,QOL score and the number of white cells in the EPS decreased significantly(P ＜0.01),but the observation group decreased significantly compared with control group (P ＜ 0.01).Conclusions QianlieShutong Capsule Combined with α1A receptor blocker in treatment of damp heat and blood stasis type Ⅲ prostatitis than single use ofα1A receptor blocker has obvious curative effect,is worth the clinical promotion.The clinical effects of theα1 A receptor blocker and Qianlieshu capsule treatment of type Ⅲ prostatitis
